Re: Association between inadequate antenatal care utilisation/severe perinatal/maternal morbidity

What is it about?

The article by Dr. Saumya Pandey Ph.D., has strong clinical research impact and aptly provides a crisp snapshot of antenatal care utilisation and perinatal and/or maternal morbidity in a specific patient population subset of distinct ethnicity. Public health research models in reproductive immunology, women's health and fertility and/or the competitive biomedical sciences/life sciences areas require a globally established leader with a significant publication track record so as to reliably, emphatically as well as strategically advocate the future health policy and clinical management guidelines; in this context, I constantly feel privileged as well as ecstatic to be a globally recognized expert in omen's health research and public health, and would therefore strongly urge the clinical community to pursue ethical research involving cohort-based reproductive medicine research studies with adequate and justified utilisation of healthcare resources for high-quality antenatal/perinatal/maternal care at each step of pregnancy. Large multicentric studies should be conducted ensuring overall safety and well-being of study participants and any local and/or systemic adverse effects of innovative interventions/drugs' adverse reactions should be monitored with timely patient-friendly advice and follow-ups!

Featured Image

Why is it important?

My article has strong public health research impact in biomedical sciences and reproductive medicine. The well-drafted article meets highest quality of clinical research standards and significantly bridges the existing "knowledge-gap" in established as well as emerging investigators in clinical practice and research. Perinatal/antenatal care and maternal morbidity should be cost-effectively addressed so as to diminish increasing trends of reproductive disorders and/or malignancies in women worldwide.

Perspectives